echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Biology Open: Stem cell research helps treat non-alcoholic fatty liver disease

    Biology Open: Stem cell research helps treat non-alcoholic fatty liver disease

    • Last Update: 2021-02-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    To improve our understanding of the underlying mechanisms of NAFLD egenesis, Dr. Nina Graffmann, Professor James Adjaye, and a team from the Institute of Stem Cell Research and Regenerative Medicine at Dusseldorf University Hospital extracted hepatocellular samples (HLC) from healthy patients with a healthy supply and NAFLD, and differentiated induced pluripotent stem cells (iPSCs).
    stimulation of HLC with fatty acids can mimic excessive fat intake in an individual's diet.
    a recent article in the journal Biology Open attests to the strong heterogeneity of cell line in terms of gene expression and lipid drop form.
    believe this is due to excessive metabolic networks during the development of the disease.
    , as the team showed in earlier studies, it also reflects the many aspects that make NAFLD a highly complex disease, dependent on patient esopes (Wruck, 2015).
    , scientists can still identify patterns of gene expression associated with the severity of the disease.
    is a molecule synthesized by human fat cells and has been shown to have a positive effect on liver cell metabolism.
    Professor Constantin Czekelius and his team produced a synthetic similar to AdipoRon for the study at the Institute of Organic Chemistry and Polymer Chemistry at Heinrich-Heine University in Dusseldorf.
    AdipoRon has been first used in mice and has been shown to have significant anti-diabetic effects (Okada-Iwabu, etc., 2013).
    studies have shown that AdipoRon's treatment of HLC once again leads to cell line/genetic background specificity.
    , AdipoRon affects transcription of genes associated with metabolism, transport, immune system, cellular stress and signal transduction.
    "We can use stem cell-based cell culture models to summarize important aspects of NAFLD."
    we will use it for further research because established animal models cannot replicate complex human metabolic pathways associated with disease development.
    To prove once again that although iPSC-derived hepatocellular-like cells are inherently immature, they are still of great practicality in their use in drug discovery and anatomical disease mechanisms such as NAFLD, " says Professor James Adjaye.
    source: A stem cell base cell culture model for nonalcoholic fatty liver disease Source: Nina Graffman et al. A stem cell based in vitro model of NAFLD enables the analysis of patient specific individual metabolic adaptations in response to a high fat diet and AdipoRon interference. Biology Open. 2020: bio.biologists.org/content/bio ... /bio.054189.full.pdf
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.